Keyphrases
Overexpression
100%
Breast Cancer Cells
100%
Antimicrotubule Agents
100%
IRF9
100%
Drug Resistance
37%
Responsive Genes
25%
Tumor Subtype
12%
Breast Tumor Cells
12%
Type I IFN
12%
Induced Expression
12%
Per Se
12%
Complementary DNA (cDNA)
12%
Human Tumors
12%
Differential Display
12%
Breast Tumor
12%
Paclitaxel
12%
Transcriptional Activation
12%
Phenotypic Expression
12%
IFN Signaling
12%
Human Cancer
12%
Uterine Tumors
12%
IFN Regulatory Factor
12%
Resistance Development
12%
Gene Analysis
12%
Resistance Phenotypes
12%
STAT2
12%
Transient Overexpression
12%
ISGF3
12%
Step Selection
12%
Breast Adenocarcinoma Cells
12%
Medicine and Dentistry
Cancer Cell
100%
Breast Cancer
100%
Antimicrotubule Agent
100%
Interferon Regulatory Factor 9
100%
Drug Resistance
37%
Neoplasm
25%
Breast Tumor
25%
Cancer
12%
Tumor Cell
12%
Mediator
12%
Paclitaxel
12%
Differential Display
12%
Complementary DNA
12%
Transcription Initiation
12%
Uterus Tumor
12%
STAT1 Protein
12%
Matched Donor
12%
Breast Adenocarcinoma
12%
Transactivation
12%
STAT2 Protein
12%
Interferon Stimulated Gene Factor 3
12%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Interferon Regulatory Factor 9
100%
Drug Resistance
37%
Neoplasm
25%
Breast Tumor
25%
Paclitaxel
12%
Complementary DNA
12%
STAT1 Protein
12%
Breast Adenocarcinoma
12%
STAT2 Protein
12%
Uterus Tumor
12%
Interferon Stimulated Gene Factor 3
12%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
IRF9
100%
Drug Resistance
37%
Mediator
12%
Transcription Initiation
12%
Transactivation
12%
Gene Analysis
12%
Differential Display
12%
Interferon Stimulated Gene Factor 3
12%
Immunology and Microbiology
Cancer Cell
100%
Interferon Regulatory Factor 9
100%
Drug Resistance
37%
Mediator
12%
Tumor Cell
12%
Transcription Initiation
12%
Transactivation
12%
Interferon Stimulated Gene Factor 3
12%